-
It’s time for structured oversight of AI in healthcare
How AI and other new technologies present novel compliance and enforcement risks and opportunities to the pharmaceutical industry.
-
Risk as a catalyst: PwC’s Tiffany Gallagher on healthcare compliance innovation
How rapid tech advance has changed healthcare’s compliance landscape.
-
Conflicts of interest in healthcare: Aaron Narva explains the tech and the processes
He talks about his AI-powered, data-driven platform and why better management of conflicts of interest can eradicate fraud and overspend.
-
Celito Tech’s Ravi Monangi and Ethan Grammer on compliant growth in life science
We explored how small and mid-sized pharmaceutical and biotech companies can avoid costly early compliance mistakes and minimize risk as they scale.
-
Podcast: Denis Jacob charts a path through regulatory uncertainty for healthcare
As leader of the ethics and compliance program at Henry Schein, Jacobs collaborates with stakeholders to ensure compliance, while prioritizing growth.
-
India must regulate to safeguard its reputation as “the world’s pharmacy”
Last year, India’s pharmaceutical industry had an annual turnover of around $65 billion. But there is potential for far greater revenue.
-
Regulatory uncertainty brings risk and opportunity to pharma in 2025, says Jeff Lemay
CCO Jeff Lemay reflects on his time at Jazz Pharmaceuticals and asseses the road ahead for compliance and legal teams in the pharma sector.
-
CMA receives offer from Vifor Pharma
If the offer is accepted, Vifor Pharma’s commitments will become legally binding and the CMA will not have to determine if the law was broken.